INVESTMENT IN RESEARCH SAVES LIVES AND MONEY
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects thousands of Americans. In individuals with ALS, nerve cells known as motor neurons located in the brain and spinal cord degenerate and eventually die. When motor neurons die, the brain loses the ability to control muscles, and people in later stages of the disease may become completely paralyzed. 1 There is currently no cure nor way of halting the disease, but research has advanced our understanding of what causes ALS and has opened doors for potential new treatments -and ultimately, a cure. 2 [1] ALS Association about ALS [ 
30,000
Americans may be living with ALS. 3
The U.S. spends about 5 cents of each health dollar on research to prevent, cure and treat disease and disability. Do you think that this is too much, the right amount, or not enough? COST $250M to 1B:
The national economic cost of ALS due to direct medical care and indirect costs, such as lost productivity. 4
$16K to $200K:
Range of annual healthcare costs for ALS on a per case basis. 4
Research Delivers Solutions
The most frequent, though not only, genetic cause of ALS appears to be a series of mutations in the C9orf72 gene, which cause toxic amounts of proteins to be produced in cells. In a new study, researchers created antibodies which can recognize and disrupt these proteins, and will examine whether the disruption alleviates symptoms of ALS. If successful, the research may point the way toward immunotherapy as a possible ALS treatment. 5 A recent study found that the abnormally high amount of certain proteins seen in ALS-affected cells interfered with the proper functioning of the STMN2 gene, which helps cells regenerate. Researchers found that by controlling STMN2 activity, they could rescue damaged cells. This discovery has strong implications for treating ALS cell damage. 6 Advances in stem cell research have given scientists new ways to develop ALS treatments. Using stem cells derived from people with ALS (which have the ability to grow into specific cell types), scientists may be able to create better models of the disease, or grow healthy neuron cells for treatment. 7 Research has shown that ALS shares some characteristics with other neurodegenerative diseases; for example, ALS is accompanied by neuroinflammation, which is also common in multiple sclerosis (MS). Scientists have seen promising results using an approved MS drug, fingolimod, to treat this aspect of ALS. 8
Then. Now. Imagine.
THEN
Prior to 1995, there were no medicines to treat ALS. 9
NOW
Research has given us a better picture of shared underlying biology between some brain diseases, opening up possibilities for drugs to be used for more than one disease. 8
IMAGINE
A cure.
